Literature DB >> 12839517

Correlation between performance on the Continuous Performance Test and economic costs in patients with schizophrenia.

Sheng Ying Ko1, Po See Chen, Yen Kuang Yang, Yi Cheng Liao, Yih Dar Lee, Tzung Lieh Yeh, Ming Jen Yang.   

Abstract

The aim of the present study was to determine whether a relationship existed between the performance on the Continuous Performance Test (CPT) and the economic costs of schizophrenic patients in Taiwan. Forty-six schizophrenic patients and their caregivers were enrolled. The CPT is a vigilance task requiring the monitoring of rapid information processing and the detection of briefly presented target stimuli. Each patients undertook two CPT sections: the unmasked task and the masked task. Economic Cost Questionnaires were used for assessing the direct and indirect costs of the illness. The patients' performance on the masked version of the CPT correlated significantly with the indirect costs, although there was no significant relationship between CPT scores and direct costs. Schizophrenic patients with more severely impaired sustained attention, particularly as measured by CPT, may incur higher indirect costs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12839517     DOI: 10.1046/j.1440-1819.2003.01134.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  3 in total

1.  Dopamine D1 receptor activation improves PCP-induced performance disruption in the 5C-CPT by reducing inappropriate responding.

Authors:  S A Barnes; J W Young; S T Bate; J C Neill
Journal:  Behav Brain Res       Date:  2015-11-30       Impact factor: 3.332

2.  Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice.

Authors:  J W Young; M A Geyer; A J Rissling; R F Sharp; L T Eyler; G L Asgaard; G A Light
Journal:  Transl Psychiatry       Date:  2013-11-12       Impact factor: 6.222

Review 3.  Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as Examples.

Authors:  Lan Gao; Hao Hu; Fei-Li Zhao; Shu-Chuen Li
Journal:  PLoS One       Date:  2016-01-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.